HENWOOD GERALDINE (President and CEO) reported 1 transaction at BAUDAX BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/23/2021ACC: 0000899243-21-049629
DirectorOfficer· President and CEO
Since Nov 2019
+802.53K
Net shares
Net buyer
$5.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
821.17K acquired · 18.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18.64K
Price / share
$0.31
Trade value
$5.78K
% of position
5.2%
12/15/2021
355.35K→336.72K
Total
Net shares
−18.64K
Net value
-$5.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/15/2021 | F · Tax Withholding | −18.64K | $0.31 | $5.78K | 5.2% | 355.35K | 336.72K |
| Total | −18.64K | -$5.78K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
821.17K shares
Shares
+821.17K
Strike price
1.70
Held after
821.17K
Exercisable
—
12/22/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock821.17K shares | 12/22/2021 | A · Award | +821.17K | 1.70 | — | 821.17K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned20K
Total
20K indirect20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 20K | Indirect |
| Total | 20K | 20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported